> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# QT Imaging Gets Clearance for Breast Scan Calculation
- URL: https://www.fdaweb.com/qt-imaging-gets-clearance-for-breast-scan-calculation/
- Published: 2022-09-23T12:00:00.000Z
- Updated: 2026-09-14T18:00:25.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5152810

FDA has granted QT Imaging a 510(k) clearance for its QTscan to calculate the fibroglandular volume of the breast and the ratio of that to total breast volume. “This ratio can contribute to an assessment of risk for breast cancer and changes in this ratio can be used to measure the efficacy of medication used to treat or prevent breast cancer,” the company says. Unlike traditional breast imaging, the company’s QTscan does not require radiation, injection, or compression, which allows earlier and more frequent monitoring for women undergoing non-surgical breast cancer treatments such as adjuvant chemotherapy, radiation therapy, cryotherapy, and hormone or selective hormone receptor modulation treatments, QT Imaging says.